Bank Of Nova Scotia An2 Therapeutics, Inc. Transaction History
Bank Of Nova Scotia
- $53.7 Billion
- Q3 2025
A detailed history of Bank Of Nova Scotia transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 459,194 shares of ANTX stock, worth $523,481. This represents 0.0% of its overall portfolio holdings.
Number of Shares
459,194
Previous 459,194
-0.0%
Holding current value
$523,481
Previous $486,000
19.96%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ANTX
# of Institutions
35Shares Held
7.57MCall Options Held
0Put Options Held
0-
Almitas Capital LLC Santa Monica, CA1.43MShares$1.63 Million0.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.08MShares$1.23 Million0.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY589KShares$671,7060.67% of portfolio
-
Stonepine Capital Management, LLC Bend, OR564KShares$642,8600.58% of portfolio
-
Landscape Capital Management, L.L.C.456KShares$520,3670.04% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $22.1M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...